Pfizer Wins Norvasc Patent Challenge By Generic Manufacturer Synthon
Sat, 02 Sep 2006 07:00 AM EST
... Pfizer Inc said today thata federal court in the Middle District of North Carolina has upheld thecompany's U.S. patent covering amlodipine besylate, the active ingredientin Norvasc, the world's most-prescribed branded medicine for treatinghypertension. The patent had been challenged by the generic manufacturer,Synthon Pharmaceuticals. Judge James A. [click link for full article] ...
Related Topics
- Amlodipine
- Patent Lean
- Patent Ductus Arteriosus
- Patent foramen ovale
- Metoprolol Oral
- Clopidogrel
- Polyethylene Glycol 3350
- Amlodipine and Atorvastatin
- Clomiphene
- Pets and Pet Health
- Drug Side Effects
- Oxytocin Injection
- Antibiotic Resistance
- Sertraline
- Amphetamine and Dextroamphetamine
- Incarceration
- Benazepril
- Triamterene and Hydrochlorothiazide
- Sterilization
- Dutasteride

Not Signed In -

